EMA looks at impact of weight on efficacy of emergency contraceptives
This article was originally published in SRA
Executive Summary
The European Medicines Agency is looking into whether the efficacy of emergency contraceptives (ECs) containing levonorgestrel or ulipristal acetate is impaired by increased bodyweight and body mass index (BMI)1.